GlassScriptPhysician profile
John H Drouilhet
NPI 1528066487
$2,251.05
in general payments reported to CMS, 2019-2025
17 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,066 · 2020: $22.73 · 2021: $142 · 2022: $526 · 2023: $135 · 2024: $108 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $494.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $387.34 | 2022-2025 | Rocklatan, Voyager Dslt, Rhopressa |
| Novartis Pharmaceuticals Corporation | $358.18 | 2019-2020 | |
| Genentech USA, INC. | $344.44 | 2019-2022 | |
| Eyevance Pharmaceuticals LLC | $155.42 | 2019 | |
| Aerie Pharmaceuticals, INC. | $144.81 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $135.88 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $116.38 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $96.42 | 2019 | |
| Horizon Therapeutics Plc | $78.53 | 2023 | Tepezza |
| Eyepoint US, INC. | $67.84 | 2021-2022 | |
| Apellis Pharmaceuticals, INC. | $67.27 | 2023-2024 | |
| Astellas Pharma US INC | $55.24 | 2023-2024 | Izervay |
| Mallinckrodt Enterprises LLC | $45.98 | 2019 | |
| Biogen, INC. | $30.44 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $28.73 | 2024 | Briviact |
| Abbvie INC. | $13.15 | 2023 | Lumigan, Alphagan P |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Drouilhet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.